LEQEMBI J Code: J0174

Drug & Product Overview

HCPCS Descriptor Lecanemab-irmb, for intravenous injection, 1 mg

HCPCS Added Date July 6, 2023

Manufacturer Eisai

Route of Administration Intravenous

Generic Status Single-Source; Branded

Dosage Type Single-Dose

Dosage Form Injection, Solution

About LEQEMBI

Leqembi is a medication aligned to the HCPCS J Code: J0174 for billing, pricing, and reimbursement purposes in the United States. This Neurology medication is administered via the intravenous route and manufactured by Eisai.

According to CMS Drug Use Information: This medication is used to treat Alzheimer's disease. It is thought to work by decreasing a certain substance (amyloid beta) that builds up in the brain of a person with Alzheimer's disease. Lecanemab belongs to a class of drugs known as monoclonal antibodies. This medication is not a cure for Alzheimer's disease. It may help slow down worsening of this disease and may delay disability.

Disclaimer: This is a summary and does not contain all possible information about this product. For complete information about this product or your specific health needs, ask your healthcare professional.

NDC Code Information

Based on publicly available CMS files. The list of NDCs below is not exhaustive.

NDC Code	Drug	Manufacturer	Billing Units / Pkg	Package Size
62856-0212-01	Leqembi	Eisai Inc.	200	200 MG / 2 ML
62856-0215-01	Leqembi	Eisai Inc.	500	500 MG / 5 ML

Login for the full NDC crosswalk View pricing, complete NDC-to-HCPCS alignments, and package details.

Login →

LEQEMBI Pricing & Reimbursement

J0174 Private Payer Reimbursement

$1.25 / HCPCS unit as of Jan 2026

National median reimbursement across major commercial payers.

Create an account on PayerPrice for more information →

Historical Graphing and Billing Calculator

per HCPCS unit

As of Q3 2026

LEQEMBI CPT Administration Codes

CPT Code	Description
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); initial, up to 1 hour
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis (specify substance or drug); each additional hour (List separately in addition to code for primary procedure)

JW / JZ modifiers apply

CMS has identified Leqembi (J0174) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. Wastage billing guide →

LEQEMBI Clinical Information

Indications and drug classification.

Treated Diseases & Conditions

This list of indications is not exhaustive and may be subject to errors. The information on BuyandBill.com is intended for informational purposes only and should not be used for medical advice.

Alzheimer's disease

Drug Class

Amyloid Beta-directed Antibody Interactions [MoA]Amyloid Beta-directed Antibody [EPC]

Frequently Asked Questions

Is there an available Leqembi billing and coding guide?

Billing and coding information for LEQEMBI can be found through EISAI INC.. Visit Here →

Are there any available Leqembi patient assistance programs?

LEQEMBI patient assistance information can be found through EISAI INC.. Visit Here →

Where can I find Leqembi prescribing information?

LEQEMBI prescribing information can be found at the link below: Visit Here →

Where can I find Leqembi side effect information?

Information regarding LEQEMBI's side effects can be found at MedlinePlus Visit Here →

Does billing LEQEMBI require JZ/JW wastage modifiers?

CMS has identified LEQEMBI(J0174) as a HCPCS code with single-dose containers. Therefore, the JW/JZ wastage modifiers could be required for billing purposes. See CMS guidelines on use of the JZ and JW wastage modifiers below.

About BuyandBill.com:

The BuyandBill.com team is dedicated to delivering high-quality coding and billing information for office-administered drugs. We continuously research HCPCS-coded medications to expand our resources and ensure data accuracy. Manufacturers: click here to sponsor your medication, and we will ensure the most accurate and detailed information is displayed.